Ecomat, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2020
April 23, 2020 at 09:02 am EDT
Share
Ecomat, Inc. announced earnings results for the third quarter ended March 31, 2020. For the third quarter, the company announced net loss was USD 18,515 compared to USD 18,834 a year ago. For the nine months, net loss was USD 61,125 compared to USD 58,006 a year ago.
Ecomax, Inc. is engaged in selling and distributing Rocitin NMN products to customers in the Territory. Rocitin NMN is a nutritional supplement manufactured by Pharmazeutische Fabrik Evers GmbH & Co. KG, a German company. Each bottle contains 60 capsules, 10080 mg of NMN. NMN, as β-Nicotinamide Mononucleotide exists in some fruits, vegetables, and poultry. It is a molecule naturally occurring in all life forms and can be transformed into a significant coenzyme NAD+ within cells, which is important to human metabolism. Its research, including Nicotinamide mononucleotide (NMN) as an anti-aging health product has shown that NAD+ levels in the body will decrease with age, and that exogenous supplementation of NMN enhances NAD+ levels and thus the function of human cells. In addition, NMN also helps to repair broken DNA, regulate the stability of DNA and cell death, and improve neurodegenerative and metabolic conditions.
ECOMAX, INC. 
